about
Neurotrophic factors in Alzheimer’s disease: role of axonal transportNovel therapeutics for Alzheimer's disease: an updateThe pharmacology and therapeutic potential of (-)-huperzine A.Acute synaptic modulation by nicotinic agonists in developing cerebellar Purkinje cells of the ratIncreased neurodegeneration during ageing in mice lacking high-affinity nicotine receptorsGypsogenin derivatives: an unexpected class of inhibitors of cholinesterases.Distinct roles of basal forebrain cholinergic neurons in spatial and object recognition memoryScopolamine disrupts hippocampal activity during allocentric spatial memory in humans: an fMRI study using a virtual reality analogue of the Morris Water Maze.Neuroprotective and cognitive enhancing activity of the fermented Bozhougyiqi-Tang.Improvements in memory after medial septum stimulation are associated with changes in hippocampal cholinergic activity and neurogenesisGonadal hormones modulate the potency of the disruptive effects of donepezil in male rats responding under a nonspatial operant learning and performance taskCarbachol-induced long-term synaptic depression is enhanced during senescence at hippocampal CA3-CA1 synapses.The cholinergic approach for the treatment of vascular dementia: evidence from pre-clinical and clinical studies.Convergence of presenilin- and tau-mediated pathways on axonal trafficking and neuronal function.Functional recovery of cholinergic basal forebrain neurons under disease conditions: old problems, new solutions?Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties.Interaction of lobed kudzuvine root, rhizoma chuanxiong with both acetylcholinesterase and beta-amyloid (Aβ1-42).An acetylcholinesterase inhibitor, eserine, induces long-term depression at CA3-CA1 synapses in the hippocampus of adult ratsGeneration of neuropeptidergic hypothalamic neurons from human pluripotent stem cells.Revisiting the Role of Acetylcholinesterase in Alzheimer's Disease: Cross-Talk with P-tau and β-AmyloidThe effect of nucleus basalis magnocellularis deep brain stimulation on memory function in a rat model of dementia.Oxidative Stress-Mediated Brain Dehydroepiandrosterone (DHEA) Formation in Alzheimer's Disease DiagnosisRoles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.Olfaction in Parkinson's disease and related disorders.Role of acetylcholinesterase inhibitors in pharmacological regulation of amyloid precursor protein processing.Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeuticsRivastigmine in Alzheimer's disease: Cognitive function and quality of life.Coactivation of M(1) muscarinic and alpha1 adrenergic receptors stimulates extracellular signal-regulated protein kinase and induces long-term depression at CA3-CA1 synapses in rat hippocampusNeuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?Perisomatic GABA release and thalamocortical integration onto neocortical excitatory cells are regulated by neuromodulators.Amyloid-beta expression in retrosplenial cortex of triple transgenic mice: relationship to cholinergic axonal afferents from medial septum.Increased Caspase-6 activity in the human anterior olfactory nuclei of the olfactory bulb is associated with cognitive impairment.Interaction of Memantine with Homocysteine on the Apoptosis in the Rat Hippocampus cells.Antioxidant approaches for the treatment of Alzheimer's disease.Review: cerebral microvascular pathology in ageing and neurodegeneration.Transcranial magnetic stimulation in Alzheimer's disease: a neurophysiological marker of cortical hyperexcitability.A review of transcranial magnetic stimulation in the in vivo functional evaluation of central cholinergic circuits in dementia.Plasticity of the human olfactory system: the olfactory bulb.Nature as a source of metabolites with cholinesterase-inhibitory activity: an approach to Alzheimer's disease treatment.Nicotine-induced enhancement of glutamatergic and GABAergic synaptic transmission in the mouse amygdala.
P2860
Q22242329-BDE7DACB-4A8B-4B80-9E74-63BBA7571EE2Q24620383-33812B99-B56C-4F95-90BC-5B7A4636EAA6Q27691305-8266C556-5696-4031-A28D-BA16B81C8581Q28344406-3212DBB0-35ED-4AA3-B8B2-08DF2DCBA3A5Q28505103-F65EABC4-57E5-40A6-8206-FF16D393EC69Q30317236-DB2DE62A-E1DA-4C3B-A948-A9896765D4E3Q30660156-7120E75D-9C8B-4425-B9A1-0EEB72C05CEEQ33686599-271CC31F-D66C-4131-9B04-0ED94FD61D60Q33833055-B2ADED7E-11C2-43EB-8F11-1120C536493CQ33914541-263539C6-E0BA-4338-8718-BF1EFAC99B80Q33918855-56296EB7-B315-49B7-9E1C-6C66C182DC1AQ34108352-7961666E-8BFC-4B5B-9BC5-802CEF832FEDQ34160743-1B2E6BB0-8656-4353-B125-1EE945E11B72Q34232597-1CF592EB-5667-44E9-9ED5-F25F83C872B0Q34771671-088A1441-C41A-4436-8E3C-34B5EA19E708Q34778803-B2EF6D0F-377F-442D-860C-7844C5F01629Q34912773-4D337100-F966-43BD-A5AA-661982B00274Q35043462-E3D5E167-B94F-42EE-8FA8-AFF25EF9DB96Q35075797-C9C4BD49-AD35-47B0-A63C-7C66D248A27AQ35210180-5BCD3DBC-A656-46C2-B4A3-D8273082096FQ35891891-A0C45C98-9939-4D97-A6BC-422235A1841AQ35972310-2423EF5B-E5D4-429E-9374-6DCCD0072325Q36076365-9BB86C00-6E8F-4D43-9150-2A68519C9101Q36193915-C16F466F-18BD-4BF5-9151-130AC57F94E0Q36479863-7F2DD2B6-F6DC-481B-BECE-C0D525B73A59Q36626374-2FF71497-D410-476B-B600-B59EDE6A773CQ36663678-05E11492-CE40-40E6-B7FF-1CE2E30A1D6EQ36763622-E53C4EA4-4D7A-4257-A2AD-82575736E76AQ36817040-69FC5EC5-5D9D-43B6-946C-1290A850471CQ36948049-738AB212-DC47-4AED-B4A6-D97620956EF4Q37442426-E1E25D2F-3CBB-4097-875B-44349471B8B2Q37487771-236666B9-9924-4A76-B32A-385E4202485AQ37576608-C41972C5-8F9D-4CF5-ACB2-C91E1772E9C9Q37768449-2E9540C9-82CF-4BFA-AE68-C049F35B659CQ37800161-6B107288-DCDF-4D40-904D-E1FD92D4FC1FQ37826097-91BCC3ED-E338-4D4D-8E28-057EB57D778AQ37912939-43B6E6EA-4DF3-429C-90D0-573B2A3BAB01Q38139229-03C64F71-6BD4-4FC4-95E4-4044F1BAEC47Q38162960-028770A9-9177-41E6-82F5-3196F1A61C51Q38299405-C2797F14-29E1-43FF-9271-189F1D83EA5B
P2860
description
1997 nî lūn-bûn
@nan
1997 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
The cholinergic system in Alzheimer's disease.
@ast
The cholinergic system in Alzheimer's disease.
@en
The cholinergic system in Alzheimer's disease.
@nl
type
label
The cholinergic system in Alzheimer's disease.
@ast
The cholinergic system in Alzheimer's disease.
@en
The cholinergic system in Alzheimer's disease.
@nl
prefLabel
The cholinergic system in Alzheimer's disease.
@ast
The cholinergic system in Alzheimer's disease.
@en
The cholinergic system in Alzheimer's disease.
@nl
P2093
P1476
The cholinergic system in Alzheimer's disease.
@en
P2093
P304
P356
10.1016/S0301-0082(97)00028-2
P577
1997-08-01T00:00:00Z